CD8A and neoplasm: This newly recognized tumor ion imbalance has emerged as a novel immunosuppressive factor, impeding the functionality of effector CD8+ T cells, fostering their exhaustion, and prompting the differentiation of tumor-associated macrophages (TAMs) into the M2 phenotype (Chen et al., 2022).